Literature DB >> 1692974

Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.

W Kromer1, E Baron, M Beinborn, R Boer, M Eltze.   

Abstract

An attempt was made to characterize the muscarine receptor type(s) involved in acid secretion in the mouse isolated stomach when stimulated by the muscarinic agonist McN-A-343. A series of 8 muscarinic antagonists was used with preference for M1 receptors (telenzepine and pirenzepine), M1 and M2 receptors (secoverine), M2 receptors (AF-DX 116 and himbacine) and M1 and M3 receptors (p-F-HHSiD and HHSiD). BTM-1086 was used as a high affinity antagonist at the M1 receptor however with little selectivity. Receptor type preferences were determined in binding experiments with [3H]telenzepine in cortical membranes (M1) and [3H]N-methylscopolamine in atrial (M2) or salivary gland (M3) membranes, derived from guinea pigs. No antagonist with M3 preference could be identified in the binding studies. A fixed antagonist concentration of 1 mumol/l was used to antagonize acid secretion stimulated by 10 mumol/l McN-A-343. By plotting the percentage inhibition obtained in the functional test against the Ki values determined in binding experiments for each antagonist at M1, M2 and M3 binding sites, an affinity-inhibition curve could only be constructed when based on the antagonist affinities to the M1 receptor. No statistically significant fit was found using antagonist affinities to the M2 or M3 receptor. Thus, in accordance with the presumed M1 selectivity of the agonist McN-A-343, the rank order of potencies of different antagonists point to the M1 nature of the muscarine receptor which stimulates acid secretion in the mouse isolated stomach upon activation by McN-A-343.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692974     DOI: 10.1007/bf00169726

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

Review 1.  Cholinergic treatments for Alzheimer's disease.

Authors:  F Roberts; S Lazareno
Journal:  Biochem Soc Trans       Date:  1989-02       Impact factor: 5.407

2.  Different binding properties of muscarinic M2-receptor subtypes for agonists and antagonists in porcine gastric smooth muscle and mucosa.

Authors:  M Herawi; G Lambrecht; E Mutschler; U Moser; A Pfeiffer
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

3.  Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.

Authors:  R E Delmendo; A D Michel; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

4.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

Review 5.  Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature.

Authors:  R M Eglen; R L Whiting
Journal:  J Auton Pharmacol       Date:  1986-12

6.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

7.  Muscarinic M2 stimulation releases histamine in the totally isolated, vascularly perfused rat stomach.

Authors:  A K Sandvik; P M Kleveland; H L Waldum
Journal:  Scand J Gastroenterol       Date:  1988-11       Impact factor: 2.423

8.  The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro.

Authors:  J A Angus; J W Black
Journal:  Eur J Pharmacol       Date:  1982-05-21       Impact factor: 4.432

9.  Analysis of anomalous pKb values for metiamide and atropine in the isolated stomach of the mouse.

Authors:  J A Angus; J W Black
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

10.  Metiamide and stimulated acid secretion from the isolated non-distended and distended mouse stomach.

Authors:  B Y Wan
Journal:  J Physiol       Date:  1977-04       Impact factor: 5.182

View more
  2 in total

1.  Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors.

Authors:  W Kromer; E Baron; R Boer; M Eltze
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

2.  Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor.

Authors:  D B Jacoby; G J Gleich; A D Fryer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.